Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 20/20 | 0.56 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.51 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26963875 | 1.00 | LGALS3 (0.56) | LGALS3LGALS1LGALS9 | |
| SCHEMBL29421119 | 1.00 | LGALS3 (0.56) | LGALS3LGALS1LGALS9 | |
| SCHEMBL22979663 | 1.00 | LGALS3 (0.56) | LGALS3LGALS1LGALS9 | |
| SCHEMBL22980636 | 0.89 | LGALS3 (0.61) | LGALS3LGALS1LGALS9 | |
| SCHEMBL22981722 | 0.89 | LGALS3 (0.61) | LGALS3LGALS1LGALS9 | |
| SCHEMBL22979692 | 0.88 | LGALS3 (0.58) | LGALS3LGALS1LGALS9 | |
| SCHEMBL22979694 | 0.88 | LGALS3 (0.58) | LGALS3LGALS1LGALS9 | |
| SCHEMBL27119856 | 0.88 | LGALS3 (0.58) | LGALS3LGALS1 | |
| SCHEMBL26963828 | 0.88 | LGALS3 (0.58) | LGALS3LGALS1 | |
| SCHEMBL26964047 | 0.88 | LGALS3 (0.58) | LGALS3LGALS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12410208-B2 | (2-acetamidyl)thio-beta-D-galactopyranoside derivatives | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-09-09 | — | — | US | claimed |
| EP-4010348-B1 | (2-ACETAMIDYL)THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2023-12-20 | — | — | EP | claimed |
| EP-4010348-A1 | (2-ACETAMIDYL)THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES | Idorsia Pharmaceuticals Ltd (CH) | 2022-06-15 | — | — | EP | claimed |
| CN-114206892-A | (2-acetamido) thio-beta-D-galactopyranoside derivatives | 爱杜西亚药品有限公司 | 2022-03-18 | — | — | CN | claimed |
| WO-2021028323-A1 | (2-ACETAMIDYL)THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2021-02-18 | — | — | WO | claimed |
| US-12410208-B2 | (2-acetamidyl)thio-beta-D-galactopyranoside derivatives | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-09-09 | — | — | US | disclosed |
| EP-4010348-B1 | (2-ACETAMIDYL)THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2023-12-20 | — | — | EP | disclosed |
| EP-4010348-A1 | (2-ACETAMIDYL)THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES | Idorsia Pharmaceuticals Ltd (CH) | 2022-06-15 | — | — | EP | disclosed |
| CN-114206892-A | (2-acetamido) thio-beta-D-galactopyranoside derivatives | 爱杜西亚药品有限公司 | 2022-03-18 | — | — | CN | disclosed |
| WO-2021028323-A1 | (2-ACETAMIDYL)THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2021-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410208-B2 | (2-acetamidyl)thio-beta-D-galactopyranoside derivatives | LGALS1, LGALS3, LGALS2 | LGALS3 2/4885LGALS1 1/4885LGALS9 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.